BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 1st Quarter - Report

MYLAN LABORATORIES INC

via GILBERT'S LLP

1st Quarter (Jan 1 - Mar 31) · 2011Posted Apr 20, 2011Filing document ↗LDA record ↗

Income$105Kfee reported

Client

Name: MYLAN LABORATORIES INC
Location: Pennsylvania · United States of America

Registrant

Firm: GILBERT'S LLP
Location: TORONTO, ON, Canada

Lobbying activities

1 issue

Health Issues
Reform to legislation and regulations affecting pharmaceutical approvals and related patent issues
Lobbyistsmr TIM GILBERT · mr NATHANIEL BRANDON LIPKUS
TargetedSENATE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

MYLAN LABORATORIES INC — Lobbying — Receipts Report